131 related articles for article (PubMed ID: 30707857)
1. Vitexin as an active ingredient in passion flower with potential as an agent for nicotine cessation: vitexin antagonism of the expression of nicotine locomotor sensitization in rats.
Bedell S; Wells J; Liu Q; Breivogel C
Pharm Biol; 2019 Dec; 57(1):8-12. PubMed ID: 30707857
[TBL] [Abstract][Full Text] [Related]
2. Passion flower extract antagonizes the expression of nicotine locomotor sensitization in rats.
Breivogel C; Jamerson B
Pharm Biol; 2012 Oct; 50(10):1310-6. PubMed ID: 22873194
[TBL] [Abstract][Full Text] [Related]
3. Effects of risperidone on development and expression of nicotine-induced locomotor sensitization in rats.
Akdag E; Kayir H; Uzbay TI
Synapse; 2011 Aug; 65(8):708-14. PubMed ID: 21108239
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine attenuates the expression of nicotine-induced locomotor sensitization in rats.
Barbosa-Méndez S; Jurado N; Matus-Ortega M; Martiñon S; Heinze G; Salazar-Juárez A
Eur J Pharmacol; 2017 Oct; 812():28-37. PubMed ID: 28668504
[TBL] [Abstract][Full Text] [Related]
5. Nicotine reversal effects of the benzoflavone moiety from Passiflora incarnata Linneaus in mice.
Dhawan K; Kumar S; Sharma A
Addict Biol; 2002 Oct; 7(4):435-41. PubMed ID: 14578021
[TBL] [Abstract][Full Text] [Related]
6. Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids.
Goutier W; Kloeze M; McCreary AC
Addict Biol; 2016 Mar; 21(2):234-41. PubMed ID: 25307867
[TBL] [Abstract][Full Text] [Related]
7. Melanin-concentrating hormone receptor antagonism differentially attenuates nicotine experience-dependent locomotor behavior in female and male rats.
Kuebler IRK; Liu Y; Bueno Álvarez BS; Huber NM; Jolton JA; Dasari R; Wakabayashi KT
Pharmacol Biochem Behav; 2023 Nov; 232():173649. PubMed ID: 37793486
[TBL] [Abstract][Full Text] [Related]
8. Blockade of nicotine sensitization by methanol extracts of Glycyrrhizae radix mediated via antagonism of accumbal oxidative stress.
Zhao ZL; Kim SC; Liu HF; Wu YY; Li LB; Wang YH; Jiao Y; Fan Y; Lee CW; Lee BH; Cho IJ; Yang CH; Zhao RJ
BMC Complement Altern Med; 2017 Nov; 17(1):493. PubMed ID: 29145840
[TBL] [Abstract][Full Text] [Related]
9. Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT.
Bhatti AS; Aydin C; Oztan O; Ma Z; Hall P; Tao R; Isgor C
Psychopharmacology (Berl); 2009 Mar; 203(1):23-32. PubMed ID: 18936914
[TBL] [Abstract][Full Text] [Related]
10. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
Goutier W; Kloeze MB; McCreary AC
Addict Biol; 2015 Mar; 20(2):248-58. PubMed ID: 24251901
[TBL] [Abstract][Full Text] [Related]
11. Clozapine inhibits development and expression of nicotine-induced locomotor sensitization in rats.
Kayir H; Goktalay G; Yildirim M; Uzbay TI
Synapse; 2009 Jan; 63(1):15-21. PubMed ID: 18925656
[TBL] [Abstract][Full Text] [Related]
12. The development and expression of locomotor sensitization to nicotine in the presence of ibogaine.
Zubaran C; Shoaib M; Stolerman IP
Behav Pharmacol; 2000 Aug; 11(5):431-6. PubMed ID: 11103895
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
Mattioli L; Perfumi M
J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
[TBL] [Abstract][Full Text] [Related]
14. Improvement in neurogenesis and memory function by administration of Passiflora incarnata L. extract applied to sleep disorder in rodent models.
Kim GH; Lim K; Yang HS; Lee JK; Kim Y; Park SK; Kim SH; Park S; Kim TH; Moon JS; Hwang IK; Yoon YS; Seo HS; Nam SM; Kim MY; Yoon SG; Seong JK; Yi SS
J Chem Neuroanat; 2019 Jul; 98():27-40. PubMed ID: 30951822
[TBL] [Abstract][Full Text] [Related]
15. Behavioural sensitization to nicotine precedes the onset of nicotine-conditioned locomotor stimulation.
Kosowski AR; Liljequist S
Behav Brain Res; 2005 Jan; 156(1):11-7. PubMed ID: 15474646
[TBL] [Abstract][Full Text] [Related]
16. The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat.
Goutier W; O'Connor JJ; Lowry JP; McCreary AC
Eur Neuropsychopharmacol; 2015 Jun; 25(6):933-43. PubMed ID: 25795518
[TBL] [Abstract][Full Text] [Related]
17. Agonist and antagonist effects of cytisine in vivo.
Radchenko EV; Dravolina OA; Bespalov AY
Neuropharmacology; 2015 Aug; 95():206-14. PubMed ID: 25839895
[TBL] [Abstract][Full Text] [Related]
18. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.
Kempsill FE; Pratt JA
Br J Pharmacol; 2000 Nov; 131(5):997-1003. PubMed ID: 11053222
[TBL] [Abstract][Full Text] [Related]
19. A two-injection protocol for nicotine sensitization.
Bernardi RE; Spanagel R
Behav Brain Res; 2014 Dec; 275():11-4. PubMed ID: 25192633
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats.
Carboni L; Romoli B; Bate ST; Romualdi P; Zoli M
Drug Alcohol Depend; 2018 Aug; 189():12-20. PubMed ID: 29857328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
